CIELO: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Basket Study of Satralizumab in Patients with NMDAR- or LGI1-Antibody Encephalitis
ANNALS OF NEUROLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined